Reduced thymus activity and infection prematurely age the immune system

Journal of Clinical Investigation

Volumn 119, Issue 10, 2009, Pages 2884-2887

  Gress, Ronald E ^a   Deeks, Steven G ^b  

^a NATIONAL CANCER INSTITUTE   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIINFLAMMATORY AGENT; CYTOMEGALOVIRUS VACCINE; GROWTH HORMONE; RECOMBINANT INTERLEUKIN 7; SOMATOMEDIN C;

AGING; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CLINICAL TRIAL; CYTOMEGALOVIRUS; CYTOMEGALOVIRUS INFECTION; DRUG MECHANISM; HUMAN; IMMUNE SYSTEM; INFECTION PREVENTION; INFLAMMATION; LYMPHOCYTE COUNT; MEMORY T LYMPHOCYTE; NONHUMAN; NOTE; PRIORITY JOURNAL; SENESCENCE; THYMECTOMY; THYMUS FUNCTION;

ADULT; AGED; AGING; HUMANS; IMMUNE SYSTEM; INFANT; INFECTION; T-LYMPHOCYTES; THYMECTOMY; THYMUS GLAND;

EID: 70349694098     PISSN: 00219738     EISSN: 15588238     Source Type: Journal    
DOI: 10.1172/JCI40855     Document Type: Note

References (21)

1. Sauce, D., et al. 2009. Evidence of premature immune aging in patients thymectomized during early childhood. J. Clin. Invest. 119:3070-3078.
2. Prelog, M., et al. 2009. Thymectomy in early childhood: significant alterations of the CD4(+) CD45RA(+)CD62L(+) T cell compartment in later life. Clin. Immunol. 130:123-132.
3. Hadrup, S.R., et al. 2006. Longitudinal studies of clonally expanded CD8 T cells reveal a repertoire shrinkage predicting mortality and an increased number of dysfunctional cytomegalovirus-specific T cells in the very elderly. J. Immunol. 176:2645-2653.
4. Wikby, A., et al. 2006. The immune risk phenotype is associated with IL-6 in the terminal decline stage: findings from the Swedish NONA immune longitudinal study of very late life functioning. Mech. Ageing Dev. 127:695-704. (Pubitemid 43949280)
5. Strindhall, J., et al. 2007. No Immune Risk Profile among individuals who reach 100 years of age: findings from the Swedish NONA immune longitudinal study. Exp. Gerontol. 42:753-761. (Pubitemid 47058867)
6. Deayton, J.R., et al. 2004. Importance of cytomegalovirus viraemia in risk of disease progression and death in HIV-infected patients receiving highly active antiretroviral therapy. Lancet. 363:2116-2121. (Pubitemid 38844151)
7. Hsue, P.Y., et al. 2006. Increased carotid intimamedia thickness in HIV patients is associated with increased cytomegalovirus-specific T-cell responses. AIDS. 20:2275-2283.
8. Peggs, K.S., et al. 2003. Reconstitution of T-cell repertoire after autologous stem cell transplantation: influence of CD34 selection and cytomegalovirus infection. Biol. Blood Marrow Transplant. 9:198-205.
9. Sylwester, A.W., et al. 2005. Broadly targeted human cytomegalovirus- specific CD4+ and CD8+ T cells dominate the memory compartments of exposed subjects. J. Exp. Med. 202:673-685.
10. Bourgeois, C., Hao, Z., Rajewsky, K., Potocnik, A.J., and Stockinger, B. 2008. Ablation of thymic export causes accelerated decay of naive CD4 T cells in the periphery because of activation by environmental antigen. Proc. Natl. Acad. Sci. U. S. A. 105:8691-8696. (Pubitemid 351987742)
11. Napolitano, L.A., et al. 2008. Growth hormone enhances thymic function in HIV-1-infected adults. J. Clin. Invest. 118:1085-1098.
12. Barton, E.S., et al. 2007. Herpesvirus latency confers symbiotic protection from bacterial infection. Nature. 447:326-329. (Pubitemid 46788830)
13. Nikolich-Zugich, J. 2008. Ageing and life-long maintenance of T-cell subsets in the face of latent persistent infections. Nat. Rev. Immunol. 8:512-522. (Pubitemid 351913675)
14. Pawelec, G., et al. 2004. Is immunosenescence infectious? Trends Immunol. 25:406-410. (Pubitemid 38951080)
15. Hakim, F.T., et al. 2005. Age-dependent incidence, time course, and consequences of thymic renewal in adults. J. Clin. Invest. 115:930-939.
16. Chu, Y.W., et al. 2008. Exogenous insulin-like growth factor 1 enhances thymopoiesis predominantly through thymic epithelial cell expansion. Blood. 112:2836-2846.
17. Williams, K.M., et al. 2008. CCL25 increases thymopoiesis after androgen withdrawal. Blood. 112:3255-3263.
18. Sutherland, J.S., et al. 2005. Activation of thymic regeneration in mice and humans following androgen blockade. J. Immunol. 175:2741-2753.
19. Sportes, C., et al. 2008. Administration of rhIL-7 in humans increases in vivo TCR repertoire diversity by preferential expansion of naive T cell subsets. J. Exp. Med. 205:1701-1714. (Pubitemid 351962032)
20. Levy, Y., et al. 2009. Enhanced T cell recovery in HIV-1-infected adults through IL-7 treatment. J. Clin. Invest. 119:997-1007.
21. Kuritzkes, D.R. 2009. Interleukin-2: trials and tribulations. J. Infect. Dis. 200:164-165.